Email a Friend
Print Article
Clinical Trials In the Public Interest
Who benefits from clinical research?
Obviously, individual participants stand to benefit from any particular clinical trial of a novel diagnosis or treatment. The new compound or method may be found to work safely and effectively on certain individuals. For those individuals, this may be the drug that cures them, or the one that makes their symptoms bearable, or that warns them they might be in the early stages of a condition that is curable if caught early on. Clearly, the most direct benefits are personal in such cases.
Groups of individuals with a condition or meeting certain criteria (such as the elderly or having a particular genetic background) may benefit from clinical research in less direct, but very significant ways. For them, the results of a clinical trial are necessary to improving the general approach to their condition.
In many cases, however, the benefits are even further removed and more abstract. Whether or not the primary hypothesis of the research is supported, solid information from the data generated by the clinical trial may be useful to the medical and scientific communities. It may not be obvious how such information would be of immediate use, but the availability of the information in the literature improves the chances that future research will be designed as intelligently as possible.
That's why it's incredibly important for the companies that sponsor clinical trials to display the utmost responsibility in collecting and analyzing data and in making it available.
Next time: Why a company called Northfield Laboratories is being criticized in this regard.
-Joe
Related Topics: Clinical Trials: Fact or Fiction Quiz, New Clinical Trial Matching Service for Breast Cancer
Technorati Tags: clinicaltrials, clinicaltrialbenefits
Obviously, individual participants stand to benefit from any particular clinical trial of a novel diagnosis or treatment. The new compound or method may be found to work safely and effectively on certain individuals. For those individuals, this may be the drug that cures them, or the one that makes their symptoms bearable, or that warns them they might be in the early stages of a condition that is curable if caught early on. Clearly, the most direct benefits are personal in such cases.
Groups of individuals with a condition or meeting certain criteria (such as the elderly or having a particular genetic background) may benefit from clinical research in less direct, but very significant ways. For them, the results of a clinical trial are necessary to improving the general approach to their condition.
In many cases, however, the benefits are even further removed and more abstract. Whether or not the primary hypothesis of the research is supported, solid information from the data generated by the clinical trial may be useful to the medical and scientific communities. It may not be obvious how such information would be of immediate use, but the availability of the information in the literature improves the chances that future research will be designed as intelligently as possible.
That's why it's incredibly important for the companies that sponsor clinical trials to display the utmost responsibility in collecting and analyzing data and in making it available.
Next time: Why a company called Northfield Laboratories is being criticized in this regard.
-Joe
Related Topics: Clinical Trials: Fact or Fiction Quiz, New Clinical Trial Matching Service for Breast Cancer
Technorati Tags: clinicaltrials, clinicaltrialbenefits
